XCellerate is a lyophilized amniotic membrane allograft.
INTENDED USES: XCellerate is used for the treatment of non-healing wounds and burn injuries. Each allograft is restricted to homologous use in procedures on a single occasion by a licensed physician or surgeon.
CLAIMED BENEFITS: XCellerate is aseptically processed to preserve the native extracellular matrix and endogenous proteins that can be used as a biological barrier or wound cover. XCellerate is a human cellular and tissue-based product. XCellerate Amniotic Membrane Allograft delivers cytokines, proteins and growth factors to help regenerate soft tissue. The amniotic membrane allograft is immune-privileged and possesses little or no risk of foreign body reaction, which can lead to fibrosis and graft failure.
OPTION: XCellerate Amniotic Membrane Allograft is available in the following size: 2 x 2 cm, 2 x 4 cm, 4 x 4 cm, 4 x 7 cm and 6 mm, 9 mm, 12 mm discs. It is applied over a wound or burn site following wound preparation in multiple sites of care. XCellerate is provided in a sterile sealed package and is intended for single use.
An invitation to view this topic will be emailed to specified recipients.
Sorry, this content is only available to registered members. Please register for FREE account to gain access.
To access this premium feature and more, upgrade to a premium plan today. Or browse to enjoy free content and tools.
WoundReference is a clinical decision support platform for experienced and new wound care clinicians at the point-of-care